Effectiveness of bariatric interventions in patients with obesity and type 2 diabetes mellitus

Obesity and type 2 diabetes mellitus (T2DM) are among the most significant components of metabolic syndrome, exerting a critical impact on the morbidity, disability and mortality of the population. In recent years, bariatric interventions have come to be regarded not only as methods of weight loss, but also as effective means of achieving remission of T2DM. Various surgical techniques, such as sleeve gastrectomy, gastric bypass, and biliopancreatic diversion, have demonstrated high rates of glycated hemoglobin reduction, decreased need for hypoglycemic drugs, and stable diabetes remission. This article summarizes data from clinical studies, randomized controlled trials, and systematic reviews published in leading international databases in recent years, allowing for an evaluation of the efficacy and safety of bariatric surgery in patients with obesity and T2DM. Particular attention is paid to the factors influencing the treatment prognosis, as well as to current concepts regarding the mechanisms underlying the metabolic effects of surgical interventions.

1. Ershova E.V., Troshina E.A. Use of bariatric surgery in type 2 diabetes mellitus: to help the practicing physician. Obesity and Metabolism. 2016;13(1):50-56. https://doi.org/10.14341/omet2016150-56.

2. Anisimova K.A., Vasilevsky D.I., Balandov S.G., Korolkov A.Yu., Khamid Z.M. Modern principles of prevention of early postoperative complications in bariatric surgery (literature review). Grekov Bulletin of Surgery. 2022;181(1):107-111. https://doi.org/10.24884/0042-4625-2022-181-1-107-111.

3. Yu Z., Li P., Li P., Zhang H., Zhang Y. Meta-analysis of long-term relapse rate of type 2 diabetes following initial remission after Roux-en-Y gastric bypass. Obes Surg. 2021;31(11):5034-5043. https://doi.org/10.1007/s11695-021-05692-4.

4. Fehervari M., Banh S., Varma P., Das B., Al-Yaqout K., Al-Sabah S., Khwaja H., Efthimiou E., Ashrafian H. Weight loss specific to indication, remission of diabetes, and short-term complications after sleeve gastrectomy conversion to Roux-en-Y gastric bypass: a systematic review and meta-analysis. Surg Obes Relat Dis. 2023;19(4):384-395. https://doi.org/10.1016/j.soard.2023.01.012.

5. Lafarge J.C., Aron-Wisnewsky J., Pattou F., Cucherat M., Blondet E., Lascols S., Le Guludec D., David D.J., Carbonneil C. French National Authority for Health assessment of metabolic surgery for type 2 diabetes remission-A meta-analysis in patients with class I to III obesity. Diabetes Metab. 2024;50(1):101495. https://doi.org/10.1016/j.diabet.2023.101495.

6. Eisenberg D., Shikora S.A., Aarts E., Aminian A., Angrisani L., Cohen R.V. еt al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022;18(12):1345-1356. https://doi.org/10.1016/j.soard.2022.08.013.

7. Rubino F., Nathan D.M., Eckel R.H., Schauer P.R., Alberti K.G., Zimmet P.Z. et al. Delegates of the 2nd Diabetes Surgery Summit. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care. 2016;39(6):861-77. https://doi.org/10.2337/dc16-0236.

8. Schauer P.R., Bhatt D.L., Kirwan J.P., Wolski K., Aminian A., Brethauer S.A. et al. STAMPEDE Investigators. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017;376(7):641-651. https://doi.org/10.1056/NEJMoa1600869.

9. Mingrone G., Panunzi S., De Gaetano A., Guidone C., Iaconelli A., Nanni G. et al. Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5-year follow-up. Lancet. 2015;386(9997):964–73. https://doi.org/10.1016/S0140-6736(15)00075-6.

10. Kim J.H., Pyo J.S., Cho W.J., Kim S.Y. The Effects of Bariatric Surgery on Type 2 Diabetes in Asian Populations: a Meta-analysis of Randomized Controlled Trials. Obes Surg. 2020;30(3):910-923. https://doi.org/10.1007/s11695-019-04257-w.

11. Yin M., Wang Y., Han M., Liang R., Li S., Wang G., Gang X. Mechanisms of bariatric surgery for weight loss and diabetes remission. J Diabetes. 2023;15(9):736-752. https://doi.org/10.1111/1753-0407.13443.

12. Pеrez-Pevida B., Escalada J., Miras A.D., Frühbeck G. Mechanisms Underlying Type 2 Diabetes Remission After Metabolic Surgery. Front Endocrinol (Lausanne). 2019;10:641. https://doi.org/10.3389/fendo.2019.00641.

13. Lafarge J.C., Aron-Wisnewsky J., Pattou F., Cucherat M., Blondet E., Lascols S. et al. French National Authority for Health assessment of metabolic surgery for type 2 diabetes remission-A meta-analysis in patients with class I to III obesity. Diabetes Metab. 2024;50(1):101495. https://doi.org/10.1016/j.diabet.2023.101495.

14. Fehervari M., Banh S., Varma P., Das B., Al-Yaqout K., Al-Sabah S. et al. Weight loss specific to indication, remission of diabetes, and short-term complications after sleeve gastrectomy conversion to Roux-en-Y gastric bypass: a systematic review and meta-analysis. Surg Obes Relat Dis. 2023;19(4):384-395. https://doi.org/10.1016/j.soard.2022.11.004.

15. Ikramuddin S., Korner J., Lee W.J., Connett J.E., Inabnet W.B., Billington C.J. et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309(21):2240-9. https://doi.org/10.1001/jama.2013.5835.

16. Meira I., Menino J., Ferreira P., Leite A.R., Gonсalves J., Ferreira H.U. et al., Diabetes Remission After Bariatric Surgery: A 10-Year Follow-Up Study. Obes. Surg. 2025;35(1):161-169. https://doi.org/10.1007/s11695-024-07592-9.

17. Courcoulas A.P., Patti M.E., Hu B., Arterburn D.E., Simonson D.C., Gourash W.F. et al. Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes. JAMA. 2024;331(8):654-664. https://doi.org/10.1001/jama.2024.0318.

18. Sheng B., Truong K., Spitler H., Zhang L., Tong X., Chen L. The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis. Obes. Surg. 2017;27(10):2724-2732. https://doi.org/10.1007/s11695-017-2866-4.

19. Dowgiałło-Gornowicz N., Jaworski P., Walędziak M., Lech P., Kucharska A., Major P.; Collaborative Study Group. Predictors of complete remission of type 2 diabetes in patients over 65 years of age - a multicenter study. Obes. Surg. 2023;33(8):2269-2275. https://doi.org/10.1007/s11695-023-06705-0.

20. Mateo-Gavira I., Sánchez-Toscano E., Mayo-Ossorio M.А., Pacheco-García J.M., Prada-Oliveira J.A., Vílchez-López F.J. Evaluation of Clinical Factors Predictive of Diabetes Remission Following Bariatric Surgery. J Clin Med. 2021;10(9):1945. https://doi.org/10.3390/jcm10091945.

21. Arterburn D.E., Telem D.A., Kushner R.F., Courcoulas A.P. Benefits and Risks of Bariatric Surgery in Adults: A Review. JAMA. 2020;324(9):879-887. https://doi.org/10.1001/jama.2020.12567.

22. Angrisani L., Santonicola A., Iovino P., Formisano G., Buchwald H., Scopinaro N. Bariatric Surgery Worldwide 2013. Obes Surg. 2015;25(10):1822-32. https://doi.org/10.1007/s11695-015-1657-z.

23. Mechanick J.I., Apovian C., Brethauer S., Garvey W.T., Joffe A.M. et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient — 2019 update. Surg Obes Relat Dis. 2020;16(2):175–247. https://doi.org/10.1016/j.soard.2019.10.025.

24. Lupoli R., Lembo E., Saldalamacchia G., Avola C.K., Angrisani L., Capaldo B. Bariatric surgery and long-term nutritional issues. World J Diabetes. 2017;8(11):464-474. https://doi.org/10.4239/wjd.v8.i11.464.

25. Dawes A.J., Maggard-Gibbons M., Maher A.R., Booth M.J., Miake-Lye I., Beroes J.M., Shekelle P.G. Mental Health Conditions Among Patients Seeking and Undergoing Bariatric Surgery: A Meta-analysis. JAMA. 2016;315(2):150-63. https://doi.org/10.1001/jama.2015.18118.

26. Borgeraas H., Hofsø D., Hertel J.K., Hjelmesaeth J. Comparison of the effect of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2020;21(6):e13011. https://doi.org/10.1111/obr.13011.

27. Moradi M., Kabir A., Khalili D., Lakeh M.M., Dodaran M.S., Pazouki A. et al. Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study. BMC Endocr Disord. 2022;22(1):260. https://doi.org/10.1186/s12902-022-01171-8.

28. Hage K., Ma P., Ghusn W., Ikemiya K., Acosta A., Vierkant R.A. еt al. A Matched Comparative Analysis of Type-2 Diabetes Mellitus Remission Between Roux-en-Y Gastric Bypass and Sleeve Gastrectomy. Surg Innov. 2024;31(2):148-156. https://doi.org/10.1177/15533506241229040.

29. Abhishek F., Ogunkoya G.D., Gugnani J.S., Kaur H., Muskawad S., Singh M. et al. Comparative Analysis of Bariatric Surgery and Non-surgical Therapies: Impact on Obesity-Related Comorbidities. Cureus. 2024;16(9):e69653. https://doi.org/10.7759/cureus.69653.

30. Ding L., Fan Y., Li H., Zhang Y., Qi D., Tang S., Cui J., He Q., Zhuo C., Liu M. Comparative effectiveness of bariatric surgeries in patients with obesity and type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials. Obes Rev. 2020;21(8):e13030. https://doi.org/10.1111/obr.13030.